Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2019-10-22 Report Publication Anno…
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Report Publication Announcement Classification · 95% confidence The document is a short, structured announcement (under 1,000 characters) detailing the results of an Investor Relations (IR) meeting held by SLS Bio. It provides logistical details such as date, location, attendees, and a link to where the actual IR materials are posted. Per the 'Menu vs Meal' rule, since this is an announcement of an event and refers to the availability of materials elsewhere rather than being the presentation itself, it is classified as a Report Publication Announcement (RPA).
2019-10-22 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a general regulatory filing/announcement.
2019-10-10 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by SLS Bio. It details the patent name, content, and application plan. Since this is a specific regulatory announcement regarding corporate activity that does not fit into financial reporting, dividend, or management change categories, it falls under the general regulatory filing category.
2019-10-04 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings Classification · 95% confidence The document is a formal regulatory announcement regarding a 'rumor or report clarification' (풍문 또는 보도에 대한 해명) filed by SLS Bio. It addresses market speculation about a KOSDAQ listing and states that no final decision has been made. As this is a standard regulatory disclosure regarding corporate developments that does not fit into specific categories like financial reports or shareholder meetings, it falls under the general regulatory filing category.
2019-09-30 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 96% confidence The document is a regulatory disclosure regarding the acquisition of a patent by SLS Bio. It provides details on the patent name, content, and utilization plan. Since it is a specific corporate announcement regarding a business development (patent acquisition) that does not fit into financial reporting, governance, or shareholder meeting categories, it falls under the general regulatory filing category.
2019-09-16 Korean
지정자문인선임계약의해지
Regulatory Filings Classification · 95% confidence The document is a short, structured announcement regarding the termination of a designated advisor contract (지정자문인 선임계약의 해지) for the company SLS Bio. It provides specific dates and reasons for the contract termination. Since it is a regulatory announcement regarding a corporate administrative change that does not fit into specific categories like M&A, Board changes, or financial reports, it falls under the general regulatory filing category.
2019-09-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.